1. Home
  2. DOMO vs PEPG Comparison

DOMO vs PEPG Comparison

Compare DOMO & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$3.91

Market Cap

132.7M

Sector

Technology

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$2.80

Market Cap

121.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
PEPG
Founded
2010
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.7M
121.7M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
DOMO
PEPG
Price
$3.91
$2.80
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$10.28
$11.17
AVG Volume (30 Days)
2.2M
1.2M
Earning Date
05-20-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
25.61
EPS
N/A
N/A
Revenue
$318,857,000.00
N/A
Revenue This Year
$3.41
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.84
$1.01
52 Week High
$18.49
$7.80

Technical Indicators

Market Signals
Indicator
DOMO
PEPG
Relative Strength Index (RSI) 56.51 66.06
Support Level $3.22 $1.60
Resistance Level $3.99 $2.62
Average True Range (ATR) 0.28 0.19
MACD 0.02 0.01
Stochastic Oscillator 50.77 93.59

Price Performance

Historical Comparison
DOMO
PEPG

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: